John Carpenter
36Patents
15h-index
41Co-inventors
81Inventor score
Filing activity: Mar 13, 1986 → May 10, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5030215A | Preparation of fibrinogen/factor XIII precipitate | Human Necessities | 188 | Expired |
| US4806343A | Cryogenic protectant for proteins | Emerging Cross-Sectional Technologies | 78 | Expired |
| US6586573B1 | Albumin-free Factor VIII formulations | Emerging Cross-Sectional Technologies | 67 | Expired |
| US5160313A | Process for preparing tissue for transplantation | Emerging Cross-Sectional Technologies | 63 | Expired |
| US5861174A | Temperature sensitive gel for sustained delivery of protein drugs | Human Necessities | 54 | Expired |
| US6482435B1 | Temperature sensitive gel for sustained delivery of protein drugs | Human Necessities | 45 | Expired |
| US8633034B2 | Methods for evaluating the aggregation of a protein in a suspension including organopolysiloxane and medical articles coated with organopolysiloxane containing a protein solution | Physics | 41 | Active |
| US5171660A | Process of revitalizing cells and tissue prior to cryopreservation | Human Necessities | 39 | Expired |
| US7087723B2 | Albumin-free factor VIII formulations | Emerging Cross-Sectional Technologies | 37 | Expired |
| US6630121B1 | Supercritical fluid-assisted nebulization and bubble drying | Emerging Cross-Sectional Technologies | 32 | Expired |
| US4897353A | Cryogenic protection of phosphofructokinase using amino acids and zinc ions | Emerging Cross-Sectional Technologies | 25 | Expired |
| US7247707B2 | Albumin-free factor VIII formulations | Emerging Cross-Sectional Technologies | 18 | Expired |
| US6489450B2 | High pressure refolding of protein aggregates and inclusion bodies | Chemistry; Metallurgy | 16 | Expired |
| US8444991B2 | Method of preparing an immunologically-active adjuvant-bound dried vaccine composition | Emerging Cross-Sectional Technologies | 16 | Active |
| US8808710B2 | Method of preparing an immunologically-active adjuvant-bound dried vaccine composition | Emerging Cross-Sectional Technologies | 15 | Active |
| US5424207A | Process of revitalizing cells prior to cryopreservation | Human Necessities | 13 | Expired |
| US7064192B2 | High pressure refolding of protein aggregates and inclusion bodies | Chemistry; Metallurgy | 12 | Expired |
| US7538198B2 | Methods for protein refolding | Chemistry; Metallurgy | 9 | Expired |
| US7829681B2 | High-pressure inclusion body solubilization and protease clipping of recombinant fusion proteins | Chemistry; Metallurgy | 8 | Active |
| US8058226B2 | Albumin-free factor VIII formulations | Emerging Cross-Sectional Technologies | 7 | Active |
| US7767795B2 | High pressure refolding of protein aggregates and inclusion bodies | Chemistry; Metallurgy | 5 | Active |
| US8372800B2 | Albumin-free factor VIII formulations | Emerging Cross-Sectional Technologies | 4 | Active |
| US8329878B2 | Methods for protein refolding | Chemistry; Metallurgy | 4 | Active |
| US7449444B2 | Hydroxyethyl starch-containing polypeptide compositions | Human Necessities | 3 | Expired |
| US8765665B2 | Albumin-free factor VIII formulations | Emerging Cross-Sectional Technologies | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.